BioCryst Pharmaceuticals Ownership | Who Owns BioCryst Pharmaceuticals?
BioCryst Pharmaceuticals Ownership Summary
BioCryst Pharmaceuticals is owned by 108.82% institutional investors, 1.20% insiders. Vanguard group is the largest institutional shareholder, holding 10.60% of BCRX shares. BioPharma Credit Ord is the top mutual fund, with 8.23% of its assets in BioCryst Pharmaceuticals shares.
BCRX Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | BioCryst Pharmaceuticals | 108.82% | 1.20% | -10.02% |
| Sector | Healthcare Stocks | 244.59% | 12.11% | -156.70% |
| Industry | Biotech Stocks | 379.61% | 11.70% | -291.31% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Vanguard group | 22.27M | 10.60% | $173.73M |
| Blackrock funding, inc. /de | 23.89M | 9.86% | $238.93M |
| Blackrock | 19.96M | 9.68% | $123.33M |
| Ra capital management | 15.83M | 6.53% | $158.27M |
| State street | 15.19M | 6.27% | $151.91M |
| Deerfield management company, l.p. (series c) | 15.10M | 6.23% | $150.96M |
| Vanguard capital management | 11.36M | 4.69% | $113.64M |
| Tcg crossover management | 11.02M | 4.55% | $110.21M |
| Perceptive advisors | 10.31M | 4.26% | $103.09M |
| Janus henderson group | 8.91M | 4.22% | $84.85M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Rp management | 3.85M | 12.84% | $29.23M |
| Rosalind advisors | 721.50K | 2.68% | $7.22M |
| Tcg crossover management | 11.02M | 2.65% | $110.21M |
| Vestal point capital, lp | 8.30M | 1.94% | $83.00M |
| Cannon global investment management | 59.70K | 1.69% | $597.00K |
| Parkman healthcare partners | 1.62M | 1.66% | $16.24M |
| Deerfield management company, l.p. (series c) | 15.10M | 1.57% | $150.96M |
| Perceptive advisors | 10.31M | 1.55% | $103.09M |
| Kynam capital management, lp | 2.52M | 1.39% | $25.23M |
| Ra capital management | 15.83M | 1.38% | $158.27M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Millennium management | 3.39M | 0.01% | 3.21M |
| State street | 15.19M | 0.00% | 2.98M |
| Perceptive advisors | 10.31M | 1.55% | 2.87M |
| Hood river capital management | 3.62M | 0.32% | 2.38M |
| Sixth street partners management company | 2.35M | 0.00% | 2.35M |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Braidwell lp | - | - | -3.38M |
| Avoro capital advisors | 1.25M | 0.12% | -3.25M |
| Kynam capital management, lp | 2.52M | 1.39% | -3.16M |
| Rfg advisory | - | - | -2.87M |
| Baker bros. advisors lp | - | - | -2.82M |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Sixth street partners management company | 2.35M | 0.00% | 2.35M | $23.53M |
| Cubist systematic strategies | 1.25M | 0.05% | 1.25M | $9.46M |
| Moore capital management, lp | 848.34K | 0.13% | 848.34K | $8.48M |
| Norges bank | 524.80K | 0.00% | 524.80K | $3.95M |
| Nan fung trinity (hk) | 450.00K | 0.44% | 450.00K | $4.50M |
Sold Out
| Holder | Change |
|---|---|
| Tfo-tdc | -3.00 |
| Aster capital management (difc) | -6.00 |
| Financial gravity asset management | -8.00 |
| Dinuzzo private wealth | -13.00 |
| Newbridge financial services group | -15.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2026 | 331 | 5.08% | 263,633,582 | 5.85% | 108 | 1.03% | 189 | -1.05% | 87 | 14.47% |
| Mar 31, 2026 | 211 | -27.49% | 108,497,915 | -48.95% | 51 | 0.50% | 123 | -13.99% | 48 | -52.00% |
| Dec 31, 2025 | 79 | -73.04% | 34,367,278 | -82.30% | 16 | 0.19% | 37 | -72.79% | 25 | -75.49% |
| Sep 30, 2025 | 101 | -65.88% | 38,849,402 | -78.37% | 18 | 0.25% | 42 | -73.58% | 35 | -57.83% |
| Jun 30, 2025 | 304 | 9.35% | 196,946,754 | 15.72% | 94 | 1.42% | 161 | 5.92% | 86 | 30.30% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| BioPharma Credit Ord | 17.22M | 8.23% | 17.22M |
| State Street® SPDR® S&P® Biotech ETF | 9.41M | 3.68% | 21.60K |
| Vanguard Total Stock Mkt Idx Inv | 8.07M | 3.18% | 11.39K |
| Vanguard Morn Total Stk Mkt Idx Investor | 8.07M | 3.18% | 11.39K |
| Vanguard MStar Total Stk Mkt Idx Invest | 8.11M | 3.17% | 37.13K |
| Vanguard US Total Market Shares ETF | 6.57M | 3.14% | -18.55K |
| iShares Russell 2000 ETF | 5.92M | 2.32% | -105.12K |
| SPDR® S&P Biotech ETF | 3.67M | 1.75% | 8.19K |
| Vanguard Small Cap Index | 2.93M | 1.15% | 6.29K |
| Vanguard Institutional Extnd Mkt Idx Tr | 2.84M | 1.11% | 4.92K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| May 18, 2026 | McKee Amy E | - | Sell | $100.28K |
| May 13, 2026 | Barnes Alane P | Chief Legal Officer | Sell | $596.25K |
| Mar 20, 2026 | HEGGIE THERESA | - | Sell | $504.82K |
| Mar 16, 2026 | Barnes Alane P | Chief Legal Officer | Sell | $1.37M |
| Dec 22, 2025 | Barnes Alane P | Chief Legal Officer | Sell | $166.56K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2026 Q4 | - | - |
| 2026 Q1 | - | - |
| 2025 Q4 | - | 6 |
| 2025 Q3 | - | 1 |
| 2025 Q2 | - | - |
BCRX Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools